Impact of diabetes mellitus on the clinical response to cardiac resynchronization therapy in elderly people (Q43905899)

27 November 2017

Impact of diabetes mellitus on the clinical response to cardiac resynchronization therapy in elderly people (English)

1 reference

27 November 2017

Celestino Sardu

1

1 reference

27 November 2017

Raffaele Marfella

series ordinal

2

1 reference

27 November 2017

Gaetano Santulli

series ordinal

3

1 reference

27 November 2017

language of work or name

English

0 references

publication date

6 February 2014

1 reference

Journal of Cardiovascular Translational Research

27 November 2017

1 reference

27 November 2017

7

1 reference

27 November 2017

3

1 reference

27 November 2017

362-368

1 reference

https://scigraph.springernature.com/pub.10.1007/s12265-014-9545-9

27 November 2017

0 references

cites work

Comparative safety and effectiveness of metformin in patients with diabetes mellitus and heart failure: systematic review of observational studies involving 34,000 patients.

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Diabetic cardiovascular disease: getting to the heart of the matter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Diabetes mellitus is associated with adverse prognosis in chronic heart failure of ischaemic and non-ischaemic aetiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Cardiac-resynchronization therapy for the prevention of heart-failure events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

QRS duration, bundle-branch block morphology, and outcomes among older patients with heart failure receiving cardiac resynchronization therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Influence of diabetes on left ventricular systolic and diastolic function and on long-term outcome after cardiac resynchronization therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Long-term outcome in diabetic heart failure patients treated with cardiac resynchronization therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Insulin-treated type 2 diabetes is associated with a decreased survival in heart failure patients after cardiac resynchronization therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Cardiac resynchronization therapy reduces the risk of cardiac events in patients with diabetes enrolled in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

The ischemic etiology of heart failure in diabetics limits reverse left ventricular remodeling after cardiac resynchronization therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Comparison of effectiveness of cardiac resynchronization therapy in patients <70 versus > or =70 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units: data from a large nationwide cardiology database (IN-CHF Registry).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

The effect of cardiac resynchronization on morbidity and mortality in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Cardiac resynchronisation therapy response predicts occurrence of atrial fibrillation in non-ischaemic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Regarding the impact of left ventricular size on response to cardiac resynchronization therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Diagnosis of gestational diabetes mellitus: can we avoid the glucose challenge test?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Insulin resistance and risk of incident heart failure: Cardiovascular Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Relation of heart-rate recovery to new onset heart failure and atrial fibrillation in patients with diabetes mellitus and preserved ejection fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Diabetes mellitus and the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Long-term effects of cardiac resynchronization therapy in octogenarians: a comparative study with a younger population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Hospitalization of patients with heart failure: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Device therapy in patients with heart failure and advanced age: too much too late?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Resynchronization: considering device-based cardiac therapy in older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

The 6 minute walking test in chronic heart failure: indications, interpretation and limitations from a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Insulin: potential negative consequences of early routine use in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial infarction: insights from the National Heart Care Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Physical activity ameliorates cardiovascular health in elderly subjects: the functional role of the β adrenergic system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Adrenergic activation, fuel substrate availability, and insulin resistance in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Adrenal signaling in heart failure: something more than a distant ship's smoke on the horizon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Comparison of the Usefulness of Cardiac Resynchronization Therapy in Three Age-Groups (<65, 65-74 and ≥75 Years) (from the InSync/InSync ICD Italian Registry)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Atrial remodelling in echocardiographic super-responders to cardiac resynchronization therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Circulating microRNA changes in heart failure patients treated with cardiac resynchronization therapy: responders vs. non-responders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-014-9545-9

Clinical response of cardiac resynchronization therapy in the elderly

21 January 2018

1 reference

12 December 2020

Improvement in diastolic function and left ventricular filling pressure induced by cardiac resynchronization therapy

1 reference

12 December 2020

Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study

1 reference

12 December 2020

Rates of complications and mortality in older patients with diabetes mellitus: the diabetes and aging study

1 reference

12 December 2020

Six-year prognosis of diabetic patients with coronary artery disease

1 reference

12 December 2020

Effect of Cardiac Resynchronization on Morbidity and Mortality of Diabetic Patients With Severe Heart Failure

1 reference

12 December 2020

10.1007/S12265-014-9545-9

Identifiers

DOI

1 reference

27 November 2017

1 reference